(1)
Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: The Evolving Canadian Landscape. Can Hematol Today 2023, 2 (3), 33-38. https://doi.org/10.58931/cht.2023.2342.